CoSaNN designs and tests an induced-fit carbohydrate kinase
CoSaNN combined neural structure prediction, learned sequence optimization and solubility ranking to design variants of an induced-fit ROK carbohydrate kinase. The authors measured expression, thermal stability and activity in vitro. The paper reports measurable expression for 189 of 348 designs in one table, while the strategy-level counts do not sum to that total; no success-rate claim is made here.
Technology: CoSaNN: AlphaFold2-based conformation modeling, ProteinMPNN sequence design and SolvIT graph neural network ranking
Family AlphaFold: profile · models page
Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.
Result, AI contribution and limits
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
- Publication status: Peer-reviewed paper
- Test type: direct test
- Tested: The authors applied CoSaNN to redesign the Arthrobacter polyphosphate glucokinase ROK kinase and performed expression, thermal-stability and enzyme-activity assays on designed variants. The primary Results table reports 189 designs with detectable soluble expression among 348 listed designs; its strategy counts (119+95+94 plus 40 in another strategy; rows in the prose/table are internally inconsistent) do not reconcile cleanly, so the record does not use a single total as a success-rate denominator.
- Still unknown: The study tests a company-designed enzyme set in vitro; it does not establish industrial deployment. The primary paper’s count inconsistency remains explicitly disclosed.
- AI role: CoSaNN uses deep-learning structure prediction (AlphaFold2), sequence optimization with ProteinMPNN and a learned solubility classifier (SolvIT) to rank enzyme designs for experimental characterization.
Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC10945820/
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: linked separately.
Review date: 17 Nov 2026. Review scope: Primary PMC full text and PNAS DOI record for CoSaNN-guided glucokinase design, Enzymit affiliations, experimental activity results and the discrepancy in reported design totals..
Editorial assessment: Impact 2/5 · Validation 3/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.
Follow-up and relationships
No follow-up recorded; this is not a claim that no follow-up exists.
Follow-up review scope and date are not recorded.
No source-supported relationships recorded.